Huntington disease: genetics and epidemiology

Area of Science:

• Neuroscience
• Genetics
• Neurology

Background:

• Huntington disease (HD) is an autosomal dominant neurodegenerative disorder.
• It is characterized by progressive chorea and dementia, typically with adult onset.
• Disease transmission often occurs before parental symptom manifestation due to late onset and lack of early markers.

Purpose of the Study:

• To summarize the key genetic, pathological, and clinical features of Huntington disease.
• To highlight the neurobiological underpinnings of the disease, including cell death and neurotransmitter system dysfunction.
• To underscore the challenges in managing HD transmission due to its clinical presentation.

Main Methods:

• Review of existing literature on Huntington disease.
• Analysis of pathological hallmarks, including neuronal loss in the striatum and other brain regions.
• Examination of neurochemical changes, such as neurotransmitter and enzyme level alterations.

Main Results:

• HD involves primary cell loss in the caudate nucleus and putamen (striatum).
• Other brain areas like the basal ganglia, hypothalamus, and brain stem are also affected.
• Significant decreases in neurotransmitter levels and enzyme activity, alongside receptor abnormalities, are observed.

Conclusions:

• Huntington disease represents a genetically programmed form of neuronal cell death in the central nervous system.
• The progressive nature and specific neuropathology of HD result in relentless deterioration.
• Understanding these mechanisms is crucial for developing future therapeutic strategies.